Chiba University may withdraw paper concerning clinical studies on Novartis’ Diovan

Apr 27, 2014

According to officials at Chiba University, reliability of the study is low, scientific falue is poor, and there may be a problem of conflict of interest.

Nikkei Biotech news release, April 27, 2014